Skip to main content
. 2016 Aug 31;10:2759–2770. doi: 10.2147/DDDT.S105142

Figure 3.

Figure 3

Effect of AZD1981 on FEV1 (A) and FVC (B) measured at the clinic during the 4-week study period in study 2.

Note: Study 2 was a 4-week, randomized, placebo-controlled dose-range finding study that assessed the efficacy and tolerability of AZD1981 in patients with asthma not controlled on ICS.

Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.